Market Insights
The development of capsule endoscopy in 2001 has given gastroenterologists the opportunity to examine the gastrointestinal tract in a non-invasive manner. Capsule endoscopy is a digital healthcare technology that can be utilized to detect gastrointestinal disorders such as gastroparesis, esophageal disease, gastrointestinal bleeding, and colon-related diseases, followed by Crohn's disease and polyposis syndrome. Capsule endoscopy has revolutionized the diagnosis of various parts of the GI system in a very simple manner. Medical professionals can gain an edge in observing the various parameters of the gastrointestinal tract, such as temperature, pressure, and pH, with the help of capsule endoscopes. Capsule endoscopy is an emerging technology that has huge potential in medical diagnostics. The existing wireless capsule endoscopes do not have the ability to treat pathologies related to the gastrointestinal tract. Realizing this, trials are being conducted to explore the direct delivery of the drug to target pathogens such as ulcers or tumors through capsule endoscopes. A capsule endoscope system consists of a wireless video capsule, a sensor array or a sensor belt, a data recorder, and a workstation with the software.
Although there are options available on the market, such as IntelliCap by Philips Electronics and Entering capsule by Phaeton Research (these systems are capable of delivering up to 1 ml of the drug to a region in the GI tract like the colon, ileum, and jejunum), these systems do not deliver the drug to the target areas like ulcers or tumors. Recently, the FDA approved the first drug, Abilify MyCite, which tracks the ingestion of medication by the patient, and physicians can monitor this activity on their phones. The system includes a sensor that transmits the information to a wearable patch.
This study, titled "Capsule Endoscopes Diagnostics Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025," states a comprehensive analysis offering company executives, investors, industry participants, and developers the opportunity to take strategic initiatives and reach verdicts related to the scenarios in the global capsule endoscopes diagnostics market. This report explains and analyses the major trends in the global capsule endoscopes diagnostics market, as well as provides market size and forecast.
This section of the report comprises segments in the form of diseases of the gastrointestinal tract and their geographical distribution. The segments are further categorized into polyp detection, Crohn's disease diagnosis, ulcer monitoring, celiac detection, tumors of the small intestine, occult gastrointestinal bleeding, diverticulosis detection, and others. Forecast and market size for the aforementioned segments are performed for the period 2015-2025, along with CAGRs for the period 2017-2025.
This report incorporates the geographical distribution into five main regions along with major countries, which are as follows:
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- Italy
- U.K.
- Russia
- Rest of Europe
- Asia-Pacific
- India
- China
- Japan
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa
The detailed description of the above-mentioned geographical market is covered for the duration of 2015–2025; the report also comprises the CAGRs for the duration of 2017–2025, which are further classified on the basis of usage area and at the country level.
An in-depth analysis is related to the market dynamics, such as drivers, restraints, and opportunities, which is presented in the report and clarifies the current trends in the market. Various tools have been used to demonstrate the competitive landscape and potential value of the market. Company profiling is also done for the major players who hold the strongest positions in the market. Some of the major players in the global capsule endoscope diagnostics market are CapsoVision, Inc., Check-Cap Ltd., Given Imaging Ltd., IntroMedic Co., Ltd., Chongqing Jinshan Science & Technology (Group) Co., Ltd., Olympus Corporation, RF Co., Ltd., Philips Healthcare, Smartpill, Inc., Siemens Healthcare, Stryker Corporation, and more.
The global capsule endoscopes diagnostics market is being studied for its application in the following areas for the purposes of this study:
- Polyps Detection
- Diagnosis of Crohn's Disease
- Ulcers Monitoring
- Celiac Detection
- Cancer of the small intestine
- Occult gastrointestinal bleeding
- Diverticulosis Detection
- Others
At present, gastrointestinal diseases are a source of considerable mortality, cost, and morbidity in the United States. According to the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) statistics, 60–70 million people in the U.S. are affected by gastrointestinal disease annually. According to data from 2004, an estimated 72 million ambulatory center visits, 4.6 million hospitalizations, and 236,000 deaths occurred from gastrointestinal diseases. The market for capsule endoscopes for diagnostic purposes is strongly supported by technological advancement. Growing life expectancy is also one of the main factors that help boost the capsule endoscope diagnostics market.
Since their discovery in the year 2000, capsule endoscopes have served as replacements for traditional endoscopes, providing a non-invasive method of inspecting the gastrointestinal tract. The increase in the prevalence of diseases related to the gastrointestinal tract and digestive system and the growth in demand for non-invasive procedures are boosting the growth of the capsule endoscope diagnostics market. Growing healthcare sectors and technological advancement are the other drivers of this market.
The global capsule endoscopes diagnostics market is being studied for its application in the following usage areas for the purposes of this study:
- Hospitals
- Ambulatory Centers
- Private Clinics
Among the considered research areas, capsule endoscopes enjoy the largest application in hospitals, followed by ambulatory centers. Higher affordability of hospitals in terms of the purchase of capsule endoscopes, the advantage of a minimal or non-invasive procedure, and an increase in the number of patients visiting hospitals for the diagnosis, treatment, and management of GI diseases are the major factors facilitating the adoption of capsule endoscopes in hospitals. It is further expected that due to the increasing preference of patients for approaching specialized private clinics for their requirements due to faster turnaround times and better treatment outcomes, the demand for capsule endoscopes from private clinics will be higher during the forecast period. Additionally, capsule endoscopy is a new introduction in the endoscopy field, and extensive research and study are being performed to boost the application of capsule endoscopes.
The global capsule endoscope diagnostics market is divided into five regions: Europe, Asia Pacific, North America, the Middle East, Africa, and Latin America.
North America and Europe held the largest share of the global capsule endoscope diagnostics market in 2016, followed by Asia Pacific, owing to major driving factors such as the rising prevalence of gastrointestinal diseases and favorable reimbursement policies. According to the estimates of the American Cancer Society, about 50,260 deaths are predicted to be caused in 2017 by colorectal cancer, which is the third leading cause of death in the United States. Because capsule endoscopy is fully secure and non-invasive, serving the growing demand for non-invasive diagnosis procedures is expected to increase in the near future. During the forecast period of 2017–2025, Asia Pacific is estimated to be the fastest-growing region due to key driving factors such as the rising prevalence of GI disease in developing countries, increasing awareness associated with early GI disease diagnosis, developing healthcare infrastructure, and mounting demand for the non-invasive procedure.
The detailed regional classification of the global diabetes drug market is as follows:
- North America (Canada and the United States)
- Asia Pacific (India, China, Japan, and the Rest of Asia Pacific)
- Europe (France, Italy, Germany, the U.K., Spain, and the Rest of Europe)
- Latin America (Brazil, Mexico, and the Rest of Latin America)
- Middle East and Africa (GCC plus the rest of the Middle East and Africa)
Request a Free Sample
Fill in your details and we'll send you a free sample report.
- Sample data tables & charts
- Research methodology
Market Dynamics
Technological Advancements in Capsule Endoscopy
Continuous innovation in capsule endoscope design, including improved imaging, battery life, and sensor integration, has enhanced diagnostic accuracy and patient comfort, driving adoption among healthcare providers.
Rising Prevalence of Gastrointestinal Diseases
The increasing incidence of GI disorders such as Crohn's disease, colorectal cancer, and gastrointestinal bleeding is fueling demand for non-invasive diagnostic tools like capsule endoscopes.
Preference for Non-Invasive Diagnostic Procedures
Patients and clinicians are increasingly opting for capsule endoscopy over traditional endoscopy due to its minimal discomfort, reduced risk of complications, and ability to access hard-to-reach areas of the GI tract.
Expanding Healthcare Infrastructure and Awareness in Emerging Markets
Developing regions, particularly in Asia Pacific, are witnessing rapid improvements in healthcare infrastructure and greater awareness of early GI disease diagnosis, accelerating market growth in these areas.
Favorable Reimbursement Policies in Developed Regions
Supportive reimbursement frameworks in North America and Europe make capsule endoscopy more accessible to patients, encouraging hospitals and clinics to invest in these advanced diagnostic devices.
Need a Custom Version of This Report?
Tailor the scope, geography, or segments to your exact requirements.
- Custom geography or segment scope
- Direct access to our analyst team
Frequently Asked Questions
What is the size of Capsule Endoscopes Diagnostics Market?
What is the Capsule Endoscopes Diagnostics Market CAGR?
What is the Forecast period considered for Capsule Endoscopes Diagnostics Market?
What is the base year considered for Capsule Endoscopes Diagnostics Market?
Who are the major players in this market?
Table of Content
Chapter 1 Market Segmentation
- 1.1 Segmentation Framework
- 1.1.1 Product and Service Classification
- 1.1.2 Application and End-Use Classification
- 1.1.3 Technology and Solution Classification
- 1.1.4 Customer and Distribution Channel Classification
- 1.1.5 Geographic Segmentation
- 1.1.6 Market Segment Definitions and Boundaries
- 1.2 By End User
- 1.2.1 Hospitals
- 1.2.2 Ambulatory Centers
- 1.2.3 Private Clinics
- 1.3 By Component
- 1.3.1 Wireless Video Capsule
- 1.3.2 Sensor Array/Belt
- 1.3.3 Data Recorder
- 1.3.4 Workstation & Software
- 1.4 By Disease Application
- 1.4.1 Polyps Detection
- 1.4.2 Diagnosis of Crohn's Disease
- 1.4.3 Ulcers Monitoring
- 1.4.4 Celiac Detection
- 1.4.5 Cancer of the Small Intestine
- 1.4.6 Occult Gastrointestinal Bleeding
- 1.4.7 Diverticulosis Detection
- 1.4.8 Others
Chapter 2 Introduction
- 2.1 Report Objectives and Scope
- 2.2 Product Definition and Industry Terminology
- 2.3 Market Inclusions and Exclusions
- 2.4 Research Process
- 2.4.1 Primary Research and Expert Interviews
- 2.4.2 Secondary Research and Source Review
- 2.4.3 Top-Down and Bottom-Up Estimation
- 2.4.4 Data Triangulation and Verification
- 2.5 Market Size Measurement Basis
- 2.5.1 Base year: USD 505.97 million → Forecast year: USD 1,158.25 million
- 2.6 Research Assumptions and Limitations
Chapter 3 Executive Summary
- 3.1 Market Snapshot and Key Findings
- 3.2 Base-Year Market Size
- 3.3 Forecast Market Size
- 3.4 Revenue and Volume Growth Outlook
- 3.5 Key Demand and Supply Indicators
- 3.6 Leading Market Segments
- 3.7 Fastest-Growing Market Opportunities
- 3.8 Regional Performance Highlights
- 3.9 Technology and Industry Transformation
- 3.10 Competitive Landscape Summary
- 3.11 Analyst View and Strategic Implications
Chapter 4 Global Capsule Endoscopes Diagnostics Market Trends and Developments
- 4.1 Historical Industry Development
- 4.2 Recent Market Trends and Developments
- 4.3 Demand and Customer Behavior Trends
- 4.4 Technology and Product Innovation
- 4.5 Artificial Intelligence, Automation and Digitalization
- 4.6 Local Manufacturing and Supply Chain Realignment
- 4.7 Industry Partnerships, Mergers and Acquisitions
- 4.8 Sustainability and Circular Economy Developments
- 4.9 Government and Private Sector Investment Trends
- 4.10 Emerging Business Models and Commercialization
- 4.11 Industry Developments and Announcements
Chapter 5 Global Capsule Endoscopes Diagnostics Market Production, Supply and Demand Analysis
- 5.1 Demand Trend and Consumption Analysis
- 5.2 Demand Forecast
- 5.3 Production and Output Trend
- 5.4 Production and Output Forecast
- 5.5 Installed Capacity and Capacity Utilization
- 5.6 Company-Wise Production Plants and Statistics
- 5.6.1 Installed Production Capacity
- 5.6.2 Actual Production
- 5.6.3 Planned Capacity and Expansion Targets
- 5.7 Supply Chain Structure and Procurement Trends
- 5.8 Supply-Demand Gap and Bottlenecks
- 5.9 Import Dependence and Sourcing Structure
- 5.10 Contract Manufacturing and Outsourcing
- 5.11 Regional Supply and Demand Concentration
Chapter 6 Global Capsule Endoscopes Diagnostics Market Pricing Analysis
- 6.1 Pricing Structure and Measurement
- 6.2 Historical Pricing Trends
- 6.3 Pricing Outlook
- 6.4 Average Selling Price and Unit Economics
- 6.5 Pricing by Product and Market Segment
- 6.6 Geographic Pricing Differences
- 6.7 Key Input, Energy, Labor and Logistics Costs
- 6.8 Contract Pricing and Purchasing Models
- 6.9 Pricing Sensitivity and Competitive Positioning
- 6.10 Price, Margin and Profitability Implications
Chapter 7 Global Capsule Endoscopes Diagnostics Market Dynamics
- 7.1 Market Growth Drivers
- 7.1.1 Demand-Side Drivers
- 7.1.2 Technology and Innovation Drivers
- 7.1.3 Infrastructure and Investment Drivers
- 7.1.4 Regulatory and Policy Drivers
- 7.2 Market Restraints
- 7.2.1 Cost and Affordability Constraints
- 7.2.2 Technology and Adoption Barriers
- 7.2.3 Supply Chain and Operational Constraints
- 7.3 Market Challenges
- 7.3.1 Competitive Pressure and Margin Erosion
- 7.3.2 Skills, Infrastructure and Implementation Gaps
- 7.4 Emerging Market Opportunities
- 7.5 Market Dynamics Impact and Time-Horizon Assessment
Chapter 8 Global Capsule Endoscopes Diagnostics Value Chain Analysis
- 8.1 Industry Value Chain Overview
- 8.2 Upstream Suppliers and Critical Inputs
- 8.3 Technology and Component Providers
- 8.4 Manufacturing or Service Delivery
- 8.5 Distribution, Channel Partners and Integrators
- 8.6 Downstream Applications and End Users
- 8.7 Value Addition and Profit Pools
- 8.8 Vertical Integration and Outsourcing
- 8.9 Supplier Concentration and Risk
- 8.10 Supply Chain Localization and Resilience
Chapter 9 Global Capsule Endoscopes Diagnostics Market Regulations and Policies
- 9.1 Relevant Laws, Standards and Compliance Frameworks
- 9.2 Product, Service, Safety and Quality Requirements
- 9.3 Government Policies, Incentives and Subsidies
- 9.4 Imports, Exports and Trade Barriers
- 9.5 Public Procurement and Local Content Requirements
- 9.6 Environmental and Sustainability Compliance
- 9.7 Upcoming Policy Changes and Market Implications
Chapter 10 Global Capsule Endoscopes Diagnostics Market Hotspots and Opportunities
- 10.1 Market Opportunity Mapping and Growth Hotspots
- 10.2 High-Growth Applications and Customer Groups
- 10.3 Underserved Markets and White-Space Opportunities
- 10.4 Emerging Technology and Product Opportunities
- 10.5 New Capacity and Investment Hotspots
- 10.6 Market Entry and Expansion Opportunities
- 10.7 Distribution and Partnership Opportunities
- 10.8 Near-Term and Long-Term Commercial Potential
- 10.9 Opportunity Attractiveness and Execution Risks
Chapter 11 Global Capsule Endoscopes Diagnostics Market Outlook
- 11.1 Market Size and Analysis
- 11.1.1 Revenue (Market Measurement: Base year: USD 505.97 million → Forecast year: USD 1,158.25 million)
- 11.1.2 Market Volume and Quantity Sold
- 11.1.3 Historical Market Size
- 11.1.4 Base-Year Market Size
- 11.2 Market Forecast
- 11.2.1 Revenue Forecast
- 11.2.2 Volume Forecast
- 11.2.3 CAGR and Year-on-Year Growth
- 11.2.4 Incremental Revenue Opportunity
- 11.3 Forecast Assumptions and Scenario Analysis
- 11.3.1 Base-Case Forecast
- 11.3.2 Optimistic and Conservative Scenarios
- 11.3.3 Technology, Pricing and Policy Sensitivities
- 11.4 Market Attractiveness and Growth Outlook
Chapter 12 Global Capsule Endoscopes Diagnostics Market Segmentation and Outlook
- 12.1 Segmentation Summary and Market Shares
- 12.2 Largest and Fastest-Growing Segments
- 12.3 By End User - Market Size and Forecast
- 12.3.1 Segment Definition and Scope
- 12.3.2 Historical Market Size
- 12.3.3 Revenue Forecast
- 12.3.4 Volume Forecast
- 12.3.5 Base-Year Market Share
- 12.3.6 Segment CAGR and Growth Drivers
- 12.3.7 Subsegment Market Size and Forecast
- 12.3.7.1 Hospitals
- 12.3.7.2 Ambulatory Centers
- 12.3.7.3 Private Clinics
- 12.3.8 Subsegment Pricing and Adoption Trends
- 12.3.9 Leading Suppliers and Competition
- 12.3.10 Regional Demand and Opportunities
- 12.4 By Component - Market Size and Forecast
- 12.4.1 Segment Definition and Scope
- 12.4.2 Historical Market Size
- 12.4.3 Revenue Forecast
- 12.4.4 Volume Forecast
- 12.4.5 Base-Year Market Share
- 12.4.6 Segment CAGR and Growth Drivers
- 12.4.7 Subsegment Market Size and Forecast
- 12.4.7.1 Wireless Video Capsule
- 12.4.7.2 Sensor Array/Belt
- 12.4.7.3 Data Recorder
- 12.4.7.4 Workstation & Software
- 12.4.8 Subsegment Pricing and Adoption Trends
- 12.4.9 Leading Suppliers and Competition
- 12.4.10 Regional Demand and Opportunities
- 12.5 By Disease Application - Market Size and Forecast
- 12.5.1 Segment Definition and Scope
- 12.5.2 Historical Market Size
- 12.5.3 Revenue Forecast
- 12.5.4 Volume Forecast
- 12.5.5 Base-Year Market Share
- 12.5.6 Segment CAGR and Growth Drivers
- 12.5.7 Subsegment Market Size and Forecast
- 12.5.7.1 Polyps Detection
- 12.5.7.2 Diagnosis of Crohn's Disease
- 12.5.7.3 Ulcers Monitoring
- 12.5.7.4 Celiac Detection
- 12.5.7.5 Cancer of the Small Intestine
- 12.5.7.6 Occult Gastrointestinal Bleeding
- 12.5.7.7 Diverticulosis Detection
- 12.5.7.8 Others
- 12.5.8 Subsegment Pricing and Adoption Trends
- 12.5.9 Leading Suppliers and Competition
- 12.5.10 Regional Demand and Opportunities
- 12.6 Segment Growth Comparison
- 12.7 Segment Attractiveness and Priority Matrix
Chapter 13 Global Capsule Endoscopes Diagnostics End-Use and Application Market Outlook
- 13.1 End-Use Industry and Customer Demand Structure
- 13.2 Leading Applications and Customer Groups
- 13.3 End-Use Market Size, Share and Forecast
- 13.4 Major End-Use Industry Deep Dives
- 13.4.1 Customer Requirements and Use Cases
- 13.4.2 Demand and Replacement Cycles
- 13.4.3 Technical and Regulatory Considerations
- 13.4.4 Purchasing and Procurement Models
- 13.4.5 Leading Vendors and Distribution Channels
- 13.4.6 Forecast and Commercial Opportunities
- 13.5 Emerging Applications and Cross-Segment Demand
- 13.6 End-Use Industry Investment Priorities
Chapter 14 Global Capsule Endoscopes Diagnostics Geographic Market Outlook
- 14.1 Regional Market Size and Share
- 14.2 Regional Market Forecast
- 14.3 Regional Pricing, Production and Demand Differences
- 14.4 North America
- 14.4.1 United States
- 14.4.2 Canada
- 14.4.3 Mexico
- 14.5 Europe
- 14.5.1 Germany
- 14.5.2 France
- 14.5.3 Italy
- 14.5.4 United Kingdom
- 14.5.5 Spain
- 14.5.6 Poland
- 14.5.7 Russia
- 14.5.8 Netherlands
- 14.5.9 Belgium
- 14.5.10 Sweden
- 14.5.11 Denmark
- 14.5.12 Norway
- 14.5.13 Rest of Europe
- 14.6 Asia Pacific
- 14.6.1 China
- 14.6.2 India
- 14.6.3 Japan
- 14.6.4 South Korea
- 14.6.5 Thailand
- 14.6.6 Indonesia
- 14.6.7 Vietnam
- 14.6.8 Malaysia
- 14.6.9 Australia
- 14.6.10 Rest of Asia Pacific
- 14.7 Latin America
- 14.7.1 Brazil
- 14.7.2 Argentina
- 14.7.3 Colombia
- 14.7.4 Chile
- 14.7.5 Rest of Latin America
- 14.8 Middle East
- 14.8.1 Saudi Arabia
- 14.8.2 United Arab Emirates
- 14.8.3 Turkey
- 14.8.4 Israel
- 14.8.5 Iran
- 14.8.6 Rest of the Middle East
- 14.9 Africa
- 14.9.1 South Africa
- 14.9.2 Egypt
- 14.9.3 Nigeria
- 14.9.4 Morocco
- 14.9.5 Rest of Africa
- 14.10 Regional Investment, Policy and Supply Chain Differences
- 14.11 Regional Competitive Landscape
- 14.12 Geographic Growth Hotspots
Chapter 15 Global Capsule Endoscopes Diagnostics Technology, Innovation and Sustainability Outlook
- 15.1 Technology Landscape and Maturity
- 15.2 Product, Process and Service Innovation
- 15.3 AI, Automation and Digital Tools in the Industry
- 15.4 Technology Adoption and Performance Benchmarking
- 15.5 Innovation Pipeline and R&D Investment
- 15.6 Patent and Intellectual Property Trends
- 15.7 Energy Efficiency and Resource Management
- 15.8 Sustainability, Recycling and Circularity
- 15.9 Technology Roadmap
- 15.10 Risks of Obsolescence and Technology Substitution
Chapter 16 Global Capsule Endoscopes Diagnostics Market Key Strategic Imperatives
- 16.1 Growth and Market Entry Priorities
- 16.2 High-Return Products and Segments
- 16.3 Pricing, Profitability and Cost Optimization
- 16.4 Technology Investment and Product Differentiation
- 16.5 Supply Chain Localization and Resilience
- 16.6 Distribution and Customer Acquisition
- 16.7 Partnership, Acquisition and Capacity Strategy
- 16.8 Regional Expansion Priorities
- 16.9 Short-, Medium- and Long-Term Actions
Chapter 17 Competition Outlook
- 17.1 Industry Competition Characteristics
- 17.2 Market Structure and Concentration
- 17.3 Market Share and Competitive Positioning
- 17.4 Company-Wise Revenue and Product Benchmarking
- 17.5 Production and Service Capacity Benchmarking
- 17.6 Technology, Pricing and Differentiation
- 17.7 Regional Footprint and Distribution Strength
- 17.8 Mergers, Acquisitions and Strategic Alliances
- 17.9 New Entrants and Competitive Threats
- 17.10 Porter's Five Forces and Industry Attractiveness
- 17.11 Competitive Outlook
Chapter 18 Company Profiles
- 18.1 Company Coverage and Selection Criteria
- 18.2 CapsoVision, Inc.
- 18.2.1 Business Description
- 18.2.2 Company Ownership and Geographic Presence
- 18.2.3 Product and Service Portfolio
- 18.2.4 Manufacturing and Operating Footprint
- 18.2.5 Production Capacity and Expansion Plans
- 18.2.6 Financial Performance and Investment
- 18.2.7 Market Share and Competitive Position
- 18.2.8 Technology and Innovation Capabilities
- 18.2.9 Strategic Alliances or Partnerships
- 18.2.10 Recent Developments
- 18.2.11 Growth Strategy and Outlook
- 18.3 Check-Cap Ltd.
- 18.4 Given Imaging Ltd.
- 18.5 IntroMedic Co., Ltd.
- 18.6 Chongqing Jinshan Science & Technology (Group) Co., Ltd.
- 18.7 Olympus Corporation
- 18.8 RF Co., Ltd.
- 18.9 Philips Healthcare
- 18.10 Smartpill, Inc.
- 18.11 Siemens Healthcare
- 18.12 Other Relevant Market Participants
Note: Every listed company is profiled on the structure shown under the first company. The company list is preliminary and may change based on research findings, market developments, data availability and client requirements.
Chapter 19 Disclaimer
- 19.1 Research and Forecast Disclaimer
- 19.2 Data Source and Estimation Limitations
Note: The depth of individual sections depends on data availability for this market. Volume, capacity, trade and other unit-based metrics are included where applicable.
